Table of Contents

    Topic review

    POMT1 Gene

    View times: 4
    Submitted by: Lily Guo
    (This entry belongs to Entry Collection "MedlinePlus ")


    protein O-mannosyltransferase 1

    1. Introduction

    The POMT1 gene provides instructions for making one piece of the protein O-mannosyltransferase (POMT) enzyme complex. The other piece is produced from the POMT2 gene. This enzyme complex is present in many different tissues in the body but is particularly abundant in the muscles used for movement (skeletal muscles), fetal brain, and testes.

    The POMT complex helps modify a protein called alpha (α)-dystroglycan. Specifically, this complex adds a sugar molecule called mannose to α-dystroglycan through a process called glycosylation. Glycosylation is critical for the normal function of α-dystroglycan.

    The α-dystroglycan protein helps anchor the structural framework inside each cell (cytoskeleton) to the lattice of proteins and other molecules outside the cell (extracellular matrix). In skeletal muscles, glycosylated α-dystroglycan helps stabilize and protect muscle fibers. In the brain, it helps direct the movement (migration) of nerve cells (neurons) during early development.

    2. Health Conditions Related to Genetic Changes

    2.1. Walker-Warburg syndrome

    At least 24 mutations in the POMT1 gene have been found to cause Walker-Warburg syndrome, the most severe form of a group of disorders known as congenital muscular dystrophies. Individuals with Walker-Warburg syndrome have skeletal muscle weakness and abnormalities of the brain and eyes. Because of the severity of the problems caused by this condition, affected individuals usually do not survive past early childhood.

    POMT1 gene mutations that cause Walker-Warburg syndrome lead to the formation of nonfunctional POMT enzyme complexes that cannot transfer mannose to α-dystroglycan, preventing its normal glycosylation. As a result, α-dystroglycan can no longer effectively anchor cells to the proteins and other molecules that surround them. Without functional α-dystroglycan to stabilize the muscle fibers, they become damaged as they repeatedly contract and relax with use. The damaged fibers weaken and die over time, which affects the development, structure, and function of skeletal muscles in people with Walker-Warburg syndrome.

    Defective α-dystroglycan also affects the migration of neurons during the early development of the brain. Instead of stopping when they reach their intended destinations, some neurons migrate past the surface of the brain into the fluid-filled space that surrounds it. Researchers believe that this problem with neuronal migration causes a brain abnormality called cobblestone lissencephaly, in which the surface of the brain lacks the normal folds and grooves and instead appears bumpy and irregular. Less is known about the effects of POMT1 gene mutations in other parts of the body.


    2.2. Other disorders

    Mutations in the POMT1 gene are also involved in less severe forms of muscular dystrophy, including muscle-eye-brain disease and POMT1-related congenital muscular dystrophy (also known as MDDGB1). Muscle-eye-brain disease is similar to Walker-Warburg syndrome (described above), although affected individuals usually survive into childhood or adolescence. POMT1-related congenital muscular dystrophy causes muscle weakness, brain abnormalities, and intellectual disability, but usually does not affect the eyes.

    POMT1 gene mutations that cause these conditions result in POMT enzyme complexes with reduced function. As a result, glycosylation of α-dystroglycan is impaired. The severity of the resulting condition appears to be related to the level of α-dystroglycan glycosylation; the less glycosylation, the more severe the condition.

    3. Other Names for This Gene

    • dolichyl-phosphate-mannose--protein mannosyltransferase 1
    • dolichyl-phosphate-mannose-protein mannosyltransferase
    • LGMD2K
    • MDDGA1
    • MDDGB1
    • MDDGC1
    • protein O-mannosyl-transferase 1
    • protein-O-mannosyltransferase 1
    • RT

    The entry is from


    1. Akasaka-Manya K, Manya H, Endo T. Mutations of the POMT1 gene found inpatients with Walker-Warburg syndrome lead to a defect of proteinO-mannosylation. Biochem Biophys Res Commun. 2004 Dec 3;325(1):75-9.
    2. Akasaka-Manya K, Manya H, Nakajima A, Kawakita M, Endo T. Physical andfunctional association of human protein O-mannosyltransferases 1 and 2. J BiolChem. 2006 Jul 14;281(28):19339-45.
    3. Balci B, Uyanik G, Dincer P, Gross C, Willer T, Talim B, Haliloglu G, Kale G, Hehr U, Winkler J, Topaloğlu H. An autosomal recessive limb girdle musculardystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburgsyndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord. 2005Apr;15(4):271-5.
    4. Bello L, Melacini P, Pezzani R, D'Amico A, Piva L, Leonardi E, Torella A,Soraru G, Palmieri A, Smaniotto G, Gavassini BF, Vianello A, Nigro V, Bertini E, Angelini C, Tosatto SC, Pegoraro E. Cardiomyopathy in patients with POMT1-relatedcongenital and limb-girdle muscular dystrophy. Eur J Hum Genet. 2012Dec;20(12):1234-9. doi: 10.1038/ejhg.2012.71.
    5. Kim DS, Hayashi YK, Matsumoto H, Ogawa M, Noguchi S, Murakami N, Sakuta R,Mochizuki M, Michele DE, Campbell KP, Nonaka I, Nishino I. POMT1 mutation resultsin defective glycosylation and loss of laminin-binding activity in alpha-DG.Neurology. 2004 Mar 23;62(6):1009-11.
    6. Lommel M, Cirak S, Willer T, Hermann R, Uyanik G, van Bokhoven H, Körner C,Voit T, Barić I, Hehr U, Strahl S. Correlation of enzyme activity and clinicalphenotype in POMT1-associated dystroglycanopathies. Neurology. 2010 Jan12;74(2):157-64. doi: 10.1212/WNL.0b013e3181c919d6.
    7. Manya H, Chiba A, Yoshida A, Wang X, Chiba Y, Jigami Y, Margolis RU, Endo T.Demonstration of mammalian protein O-mannosyltransferase activity: coexpressionof POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci U S A.2004 Jan 13;101(2):500-5.


    1. Please check and comment entries here.